538 - Sub-lethal hyperthermia enhances the anticancer activity of doxorubicin against acute hypoxic HepG2 cells through ROS-dependent mechanisms
SIR ePoster library. Xia X. 03/28/20; 289782; 538
Xiangwen Xia
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Poster Title: Sub-lethal hyperthermia enhances the anticancer activity of doxorubicin against acute hypoxic HepG2 cells through ROS-dependent mechanisms
Poster number: 538
Category: Interventional Oncology: Chemoembolization
Authors: X Xia1, T Ye2
Keywords: 0538, Xiangwen Xia Sub-lethal hyperthermia enhances the anticancer activity of doxorubicin against acute hypoxic HepG2 cells through ROS-dependent mechanisms Sub-lethal hyperthermia enhances the anticanc
Poster number: 538
Category: Interventional Oncology: Chemoembolization
Authors: X Xia1, T Ye2
Keywords: 0538, Xiangwen Xia Sub-lethal hyperthermia enhances the anticancer activity of doxorubicin against acute hypoxic HepG2 cells through ROS-dependent mechanisms Sub-lethal hyperthermia enhances the anticanc
Poster Title: Sub-lethal hyperthermia enhances the anticancer activity of doxorubicin against acute hypoxic HepG2 cells through ROS-dependent mechanisms
Poster number: 538
Category: Interventional Oncology: Chemoembolization
Authors: X Xia1, T Ye2
Keywords: 0538, Xiangwen Xia Sub-lethal hyperthermia enhances the anticancer activity of doxorubicin against acute hypoxic HepG2 cells through ROS-dependent mechanisms Sub-lethal hyperthermia enhances the anticanc
Poster number: 538
Category: Interventional Oncology: Chemoembolization
Authors: X Xia1, T Ye2
Keywords: 0538, Xiangwen Xia Sub-lethal hyperthermia enhances the anticancer activity of doxorubicin against acute hypoxic HepG2 cells through ROS-dependent mechanisms Sub-lethal hyperthermia enhances the anticanc
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}